Brian M Stuglik is Director of PUMA BIOTECHNOLOGY, INC.. Currently has a direct ownership of 76,058 shares of PBYI, which is worth approximately $244,146. The most recent transaction as insider was on Jun 18, 2024, when has been sold 27,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 76.1K
0% 3M change
137.99% 12M change
Total Value Held $244,146

Brian M Stuglik Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 18 2024
BUY
Grant, award, or other acquisition
-
27,000 Added 26.2%
76,058 Common Stock
Jun 13 2024
SELL
Open market or private sale
$33,561 $3.39 p/Share
9,900 Reduced 16.79%
49,058 Common Stock
Jun 13 2023
SELL
Open market or private sale
$34,254 $3.46 p/Share
9,900 Reduced 23.65%
31,958 Common Stock
Jun 13 2023
BUY
Grant, award, or other acquisition
-
27,000 Added 31.41%
58,958 Common Stock
Jun 16 2022
SELL
Open market or private sale
$34,970 $2.69 p/Share
13,000 Reduced 23.7%
41,858 Common Stock
Jun 14 2022
BUY
Grant, award, or other acquisition
-
27,000 Added 32.98%
54,858 Common Stock
Jun 15 2021
BUY
Grant, award, or other acquisition
-
27,858 Added 50.0%
27,858 Common Stock

Also insider at

VSTM
Verastem, Inc. Healthcare
BMS

Brian M Stuglik

Director
Needham, MA

Track Institutional and Insider Activities on PBYI

Follow PUMA BIOTECHNOLOGY, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PBYI shares.

Notify only if

Insider Trading

Get notified when an Puma Biotechnology, Inc. insider buys or sells PBYI shares.

Notify only if

News

Receive news related to PUMA BIOTECHNOLOGY, INC.

Track Activities on PBYI